Pharsight

Doryx patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6958161 MAYNE PHARMA Modified release coated drug preparation
Dec, 2022

(1 year, 6 months ago)

US8715724 MAYNE PHARMA Tabletting process
Feb, 2028

(3 years from now)

Doryx is owned by Mayne Pharma.

Doryx contains Doxycycline Hyclate.

Doryx has a total of 2 drug patents out of which 1 drug patent has expired.

Expired drug patents of Doryx are:

  • US6958161

Doryx was authorised for market use on 19 December, 2014.

Doryx is available in tablet, delayed release;oral dosage forms.

Doryx can be used as to treat or prevent infections caused by susceptible bacteria using delayed-release tablets consisting of doxycycline hyclate coated pellets in a tablet.

The generics of Doryx are possible to be released after 03 February, 2028.

Drug Exclusivity Drug Exclusivity Expiration
New Strength(NS) Apr 11, 2016
New Dosing Schedule(D-136) Apr 11, 2016

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using DOXYCYCLINE HYCLATE ingredient

Market Authorisation Date: 19 December, 2014

Treatment: To treat or prevent infections caused by susceptible bacteria using delayed-release tablets consisting of doxycycline hyclate coated pellets in a tablet

Dosage: TABLET, DELAYED RELEASE;ORAL

How can I launch a generic of DORYX before it's drug patent expiration?
More Information on Dosage

DORYX family patents

Family Patents